Halozyme Therapeutics Ownership | Who Owns Halozyme Therapeutics?
Halozyme Therapeutics Ownership Summary
Halozyme Therapeutics is owned by 98.37% institutional investors, 1.08% insiders, and 0.55% retail investors. Blackrock is the largest institutional shareholder, holding 13.88% of HALO shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.26% of its assets in Halozyme Therapeutics shares.
HALO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Halozyme Therapeutics | 98.37% | 1.08% | 0.55% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 17.62M | 13.88% | $922.58M |
| Vanguard group | 12.88M | 10.15% | $674.47M |
| State street | 5.81M | 4.58% | $304.43M |
| Snyder capital management l p | 4.04M | 3.18% | $211.53M |
| Artisan partners limited partnership | 3.72M | 2.93% | $194.64M |
| Alliancebernstein | 3.55M | 2.80% | $185.83M |
| Macquarie group | 3.08M | 2.42% | $161.14M |
| Jpmorgan chase | 3.07M | 2.42% | $160.84M |
| Geode capital management | 3.03M | 2.39% | $158.64M |
| Td asset management | 2.37M | 1.86% | $123.88M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Snyder capital management l p | 4.04M | 4.74% | $211.53M |
| Future fund | 36.30K | 4.74% | $1.89M |
| Steamboat capital partners | 177.56K | 3.41% | $9.30M |
| 2xideas | 498.96K | 3.26% | $26.13M |
| Koa wealth management | 82.41K | 3.22% | $3.94M |
| Castellan group | 116.47K | 2.41% | $5.57M |
| Bernzott capital advisors | 93.98K | 2.22% | $4.49M |
| Harvey capital management | 185.44K | 2.09% | $8.87M |
| Pier capital | 220.45K | 1.72% | $11.54M |
| Granite investment partners | 752.84K | 1.63% | $39.42M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 1.22M | 0.01% | 1.22M |
| Frontier capital management | 846.23K | 0.44% | 602.19K |
| Millennium management | 423.19K | 0.01% | 291.12K |
| Handelsbanken fonder ab | 1.11M | 0.25% | 284.30K |
| Ubs asset management americas | 432.02K | 0.01% | 271.07K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Thrivent financial for lutherans | 942.83K | 0.10% | -772.01K |
| State street | 5.81M | 0.01% | -673.10K |
| Blackrock | 17.62M | 0.02% | -621.61K |
| Allspring global investments | 46.53K | 0.00% | -556.77K |
| Lazard asset management | 452.56K | 0.03% | -353.42K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.22M | 0.01% | 1.22M | $63.68M |
| Corebridge financial | 227.12K | 0.07% | 227.12K | $11.89M |
| Lombard odier asset management (europe) | 200.00K | 0.50% | 200.00K | $10.47M |
| Nicholas investment partners, lp | 152.87K | 0.83% | 152.87K | $8.00M |
| Abrdn | 128.67K | 0.01% | 128.67K | $6.15M |
Sold Out
| Holder | Change |
|---|---|
| Harbor investment advisory | -4.00 |
| Newbridge financial services group | -10.00 |
| Jnba financial advisors | -24.00 |
| Nelson, van denburg & campbell wealth management group | -26.00 |
| Continuum advisory | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 510 | 9.68% | 124,779,138 | 2.05% | 98 | 1.06% | 270 | 11.57% | 165 | 3.77% |
| Jun 30, 2024 | 458 | 9.05% | 122,203,811 | -0.27% | 96 | 1.03% | 237 | 8.22% | 158 | 11.27% |
| Mar 31, 2024 | 420 | -0.24% | 122,538,335 | -1.36% | 96 | 1.09% | 219 | 2.82% | 142 | -0.70% |
| Dec 31, 2023 | 421 | 5.25% | 124,225,834 | 2.20% | 94 | 1.11% | 213 | 18.33% | 143 | -2.05% |
| Sep 30, 2023 | 400 | 4.71% | 121,555,932 | -1.37% | 92 | 1.05% | 180 | -0.55% | 146 | 9.77% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 4.14M | 3.26% | 13.74K |
| Vanguard Total Stock Mkt Idx Inv | 4.00M | 3.14% | 3.73K |
| iShares Russell 2000 ETF | 3.33M | 2.62% | -12.80K |
| Vanguard Small Cap Index | 3.24M | 2.55% | 43.51K |
| Aviva Investors GlConvtAbsRet I USD Acc | 2.74M | 2.16% | 2.74M |
| SPDR® S&P Biotech ETF | 2.47M | 1.94% | -28.81K |
| Vanguard Explorer Inv | 1.98M | 1.56% | 152.32K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.93M | 1.52% | 35.30K |
| Vanguard Small Cap Growth Index Inv | 1.84M | 1.44% | 78.59K |
| T. Rowe Price Integrated US SmCapGrEq | 1.75M | 1.38% | 821.32K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 06, 2025 | Henderson Jeffrey William | - | Sell | $500.06K |
| Oct 15, 2024 | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | $4.18K |
| Oct 15, 2024 | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | $533.29K |
| Oct 16, 2024 | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | $532.59K |
| Oct 08, 2024 | Torley Helen | PRESIDENT AND CEO | Sell | $49.12K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 8 |
| 2024 Q3 | - | 25 |
| 2024 Q2 | - | 10 |
| 2024 Q1 | - | 6 |
| 2023 Q4 | - | 6 |
HALO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools